Literature DB >> 2033917

Pulmonary mucormycosis presenting as massive fatal hemoptysis in a hemodialytic patient with chronic renal failure.

S Yagihashi1, K Watanabe, K Nagai, M Okudaira.   

Abstract

A 38 year old female patient died following massive hemoptysis occurring during maintenance hemodialysis for chronic renal failure. In addition to renal dysfunction, laboratory data showed low levels of serum immunoglobulins; chest X-rays did not reveal any abnormal shadows. For the last 11 months, the patient had not received deferoxamine. At autopsy, major bronchi were plugged with coagulated blood. Irregular thickening of the right main bronchial wall close to the lung hilus was noted. Light microscopic examination disclosed mycotic granulomata in the bronchial wall, where the pulmonary arterial wall was also involved. Immunostaining using specific antibody identified Mucor hyphae. The mucormycosis is a serious complication of chronic renal failure and hemodialysis. In the current case, it is likely that immune dysfunction rather than deferoxamine was the important predisposing factor to the growth of the fungus.

Entities:  

Mesh:

Year:  1991        PMID: 2033917     DOI: 10.1007/bf01646947

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  Phycomycosis. A clinicopathologic study of fifty-one cases.

Authors:  B R STRAATSMA; L E ZIMMERMAN; J D GASS
Journal:  Lab Invest       Date:  1962-11       Impact factor: 5.662

2.  Pulmonary mucormycosis with massive fatal hemoptysis.

Authors:  H W Murray
Journal:  Chest       Date:  1975-07       Impact factor: 9.410

3.  Mucormycosis among patients on dialysis.

Authors:  J R Boelaert; A Z Fenves; J W Coburn
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

4.  Fatal phycomycosis in a hemodialyzed patient receiving deferoxamine.

Authors:  K Sombolos; H Kalekou; K Barboutis; V Tzarou
Journal:  Nephron       Date:  1988       Impact factor: 2.847

5.  Zygomycosis requiring amputation of the hand: an isolated case in a patient receiving haemodialysis.

Authors:  P G Kerr; H Turner; A Davidson; C Bennett; M Maslen
Journal:  Med J Aust       Date:  1988-03-07       Impact factor: 7.738

6.  Rhinocerebral mucormycosis in an anephric patient.

Authors:  D J Morris; P Altus
Journal:  South Med J       Date:  1988-03       Impact factor: 0.954

7.  T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency.

Authors:  J L Touraine; F Touraine; J P Revillard; J Brochier; J Traeger
Journal:  Nephron       Date:  1975       Impact factor: 2.847

Review 8.  The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.

Authors:  J R Boelaert; G F van Roost; P L Vergauwe; J J Verbanck; C de Vroey; M F Segaert
Journal:  Clin Nephrol       Date:  1988-05       Impact factor: 0.975

9.  The changing spectrum of disease, etiology, and diagnosis of mucormycosis.

Authors:  A M Marchevsky; E J Bottone; S A Geller; D K Giger
Journal:  Hum Pathol       Date:  1980-09       Impact factor: 3.466

10.  Phycomycosis of the bronchus.

Authors:  R M Winston
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

View more
  2 in total

1.  Isolated pulmonary mucormycosis in an apparently normal host: a case report.

Authors:  A Butala; B Shah; Y T Cho; M F Schmidt
Journal:  J Natl Med Assoc       Date:  1995-08       Impact factor: 1.798

2.  Chronic renal failure presenting for the first time as pulmonary mucormycosis with a fatal outcome.

Authors:  B Jayakrishnan; Jamal Al Aghbari; Dawar Rizavi; Sinnakirouchenan Srinivasan; Ritu Lakhtakia; Dawood Al Riyami
Journal:  Case Rep Nephrol       Date:  2015-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.